Primus Pharmaceuticals

What Primus Pharmaceuticals does

Primus Pharmaceuticals is a privately held Indian pharmaceutical manufacturer founded on March 31, 2010, headquartered in Ambala with its production facility in Kala Amb, Himachal Pradesh. The company operates four dedicated plants producing a full range of dosage forms including pellets, tablets and hard gelatin capsules, liquid syrups and suspensions, dry and liquid injectables, eye and ear drops, ointments, creams, gels, lotions, nutraceuticals, and cosmetic preparations. Its proprietary product portfolio is organized across 13 therapeutic divisions such as Critical Care, Dermacare (Primus Dermis), Gynae Care, Heart Care, Neuro Care, Ophthalmology, Orthocare, Pediatrics, Ayurveda, and Urology, and includes more than 100 formulations reported as First Time in India.

The company sells through two interlocking commercial channels. First, it markets and distributes its own branded products via a direct sales force that promotes products across more than 100,000 doctors in India. Second, it offers third-party contract manufacturing, supplying tablets, capsules, injectables, oral liquids, pellets, and external preparations under client brands and granting business associates complete marketing and distribution rights in their respective geographies. Manufacturing is conducted under WHO-GMP, GMP, GLP, and ISO 9001:2015 certifications with DCGI approvals and a centralized quality-control and R&D function.

Revenue is generated from proprietary product sales, third-party manufacturing contracts, and licensing of marketing and distribution rights to business associates. Customers comprise pharmaceutical marketing companies, regional distributors and business associates, and institutional healthcare providers across India. Ownership remains with founders Mr. S. K. Dua (Managing Director) and Mr. Vikas Dua (Partner); no external institutional investors or public listing has been disclosed.

Name

Primus Pharmaceuticals

Legal name

Primus Pharmaceuticals

Website

https://primuspharmaceutical.com

Company type

Private

Founded year

2010

Operating status

Operating

Headcount range

51–100 employees

Short description

Primus Pharmaceuticals is a privately held Indian manufacturer of branded and third-party pharmaceutical products across tablets, capsules, injectables, liquids, pellets, and dermatological formulations, serving business associates, healthcare providers, and 100,000+ doctors in India.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Biological Product (except Diagnostic) Manufacturing (325414), Medicinal and Botanical Manufacturing (325411), Pharmaceutical and Medicine Manufacturing (3254)

SIC

Pharmaceutical Preparations (2834), Biological Products, (No Disgnostic Substances) (2836), Ophthalmic Goods (3851), Perfumes, Cosmetics & Other Toilet Preparations (2844), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Primary Care & General Medicine Pharmaceuticals (HLAIAAAA)

akta.pro secondary industries

Specialty Care Pharmaceuticals (HLAIAAAB), Small-Molecule Generics (Branded/Unbranded) (HLAIABAA), Dermatology Specialty Pharmaceuticals (HLAIACAL), Specialty Pharmaceutical Distributors (HLAIAJAB)

Keywords

• Pharmaceutical manufacturing
• Contract pharmaceutical manufacturing
• Generic pharmaceutical products
• Pharmaceutical product distribution
• Critical care pharmaceuticals

Headquarters

HQ city

Ambala

HQ country

India

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Supply Chain, Personnel, Technology or R&D, Marketing or Sales

Revenue model

1. Third-Party Manufacturing Services: Manufacturing pharmaceutical products under the name or trademark of another company. Brand is based on marketing, sales and distribution while manufacturing is handled by Primus Pharmaceuticals. Provides opportunity to pharmaceutical professionals to establish their pharmaceutical business.
2. Proprietary Product Sales: Sale of company's own branded pharmaceutical products across multiple therapeutic categories including Critical Care, Dermacare, Gynae Care, Hospital Care, Heart Care, Neuro Care, Ophthalmology, Orthocare, Ayurveda, Pediatric Care, and Urology.
3. Marketing Rights Licensing: Offering complete marketing and distribution rights to business associates for establishing pharmaceutical business in respective areas.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Core offering

Primus Pharmaceuticals manufactures and distributes a wide range of pharmaceutical products across multiple therapeutic categories including Critical Care, Dermatology (Primus Dermis), Gynecology (Gynae Care), Cardiology, Diabetology, Orthopedics, Pediatric Care, and Nutraceuticals. The company operates WHO-GMP certified manufacturing facilities in Kala Amb, India, producing multiple dosage forms including tablets, capsules, soft gels, injections, syrups, ointments, eye/ear drops, and pellets. In addition to its own branded products, Primus Pharmaceuticals offers third-party contract manufacturing services to other pharmaceutical companies.

Product overview

Primus Pharmaceuticals is a WHO-certified pharmaceutical company in India offering a diversified portfolio of pharmaceutical products and contract manufacturing services. The company operates through multiple product divisions including Critical Care (injectables), Primus Dermis (dermatology), Gynae Care (women's health), Hospital Care, Heart Care, Kyan Biotech, Neuro Care, Opthocare (ophthalmics), Orthocare, Primus Ayurveda (herbal), Pedia Care (pediatric), Primecare, and Urocare. Their manufacturing capabilities span tablets, hard gelatin capsules, liquid syrups and suspensions, dry/liquid injections, eye/ear drops, ointments, creams, gels, lotions, nutraceuticals, cosmetic preparations, and pellets. The company also offers third-party manufacturing services to pharmaceutical professionals, providing complete marketing and distribution rights to business associates.

Differentiator

Problem solved

Functional benefit

Brands

• Primus Dermis: Derma care product division offering tablets, capsules, syrups, medicated soaps, ointments, and lotions for skin infections and skincare.
• Kyan Biotech
• Primus Ayurveda

Products and services

• Critical Care Pharmaceuticals Pharmaceutical products for critical care therapeutic use, manufactured at the company's Kala Amb facility.
• Primus Dermis Dermatology-focused pharmaceutical product line offered by Primus Pharmaceuticals.
• Gynae Care Gynecology-focused pharmaceutical product line offered by Primus Pharmaceuticals.
• Third-Party Manufacturing Services Contract manufacturing services for pharmaceutical companies, leveraging the company's WHO-GMP certified facility and multi-dosage-form production capabilities (tablets, capsules, soft gels, injections, syrups, ointments, pellets, eye/ear drops).
• Pharmaceutical Products (multi-therapeutic portfolio) Branded pharmaceutical products spanning Cardiology, Diabetology, Orthopedics, Pediatric Care, Nutraceuticals and other therapeutic categories, produced in multiple dosage forms at the Kala Amb manufacturing facility and distributed through the company's business associate network.

Quantifiable outcome

• Established as WHO certified company in India with products trusted by millions of people
• +1 more outcomes

Named customers2 records

Segments4 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators3 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Alkem Laboratories: Indian pharmaceutical manufacturer with branded formulations across multiple therapeutic areas and in-house manufacturing across dosage forms; comparable as a domestic branded generics producer with similar multi-specialty portfolio structure to Primus.
• Mankind Pharma: India-focused branded generics manufacturer with strong field force and broad primary care/specialty portfolio; directly comparable as a domestic Indian pharma operator with multi-therapeutic divisions and physician-led promotion similar to Primus's GTM.
• Emcure Pharmaceuticals: Indian pharmaceutical company that combines branded formulations with B2B/contract manufacturing across multiple dosage forms; relevant peer given Primus's dual branded-plus-third-party-manufacturing model.
• Hikal Pharmaceuticals: Indian pharmaceutical manufacturer providing API and contract manufacturing/formulation services across dosage forms; comparable as a domestic Indian CDMO/formulation manufacturer with multi-dosage capability.
• Piramal Pharma Solutions: India-headquartered CDMO offering contract development and manufacturing across multiple dosage forms including injectables; directly comparable as a services-led Indian pharma manufacturer serving external clients in addition to in-house brands.

Broad incumbents

• Torrent Pharmaceuticals: India-focused pharmaceutical company with branded generics across therapeutic categories and in-house manufacturing; comparable broad incumbent competing with Primus in Indian specialty and primary care markets.
• Aurobindo Pharma: Major Indian pharmaceutical manufacturer with a wide generics portfolio including injectables and sterile formulations; an incumbent competing with Primus in hospital and critical care injectables launched in 2020.
• Cipla: One of India's largest pharmaceutical companies with a broad branded generics portfolio across multiple therapeutic segments and dosage forms; an incumbent at vastly larger scale that competes with Primus in Indian primary care and specialty formulations.
• Dr. Reddy's Laboratories: Major Indian pharmaceutical manufacturer across formulations, APIs, and biologics with global footprint; comparable as a broad incumbent offering similar therapeutic categories plus biologics that overlap with Primus's Kyan Biotech and Specialty Care divisions.
• Lupin: Large Indian pharmaceutical manufacturer with branded generics, APIs, and biosimilars across multiple therapeutic areas; an incumbent peer competing with Primus in primary care and specialty formulations across dosage forms.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/PharmaPrimus
• LinkedInlinkedin.com/company/primus-pharmaceuticals-950413132

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Primus Pharmaceuticals